- Report
- April 2025
- 487 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 414 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 409 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 200 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 62 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 194 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- September 2024
- 135 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- September 2024
- 139 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- August 2024
- 145 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- August 2024
- 147 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- July 2024
- 142 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- July 2024
- 136 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- May 2024
- 129 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- February 2025
- 120 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- January 2025
- 120 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- November 2024
- 120 Pages
Global
From €5416EUR$5,950USD£4,600GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more